Research Development of Radiation-Induced Lymphopenia

When radiotherapy is administered, many patients exhibit a reduction in lymphocyte numbers due to the inherent radio-sensitivity of lymphocytes. In particular, they experience a decrease in CD8+ T cells, which may weaken their mediated antitumor immune response. While radiotherapy activates the immu...

Full description

Saved in:
Bibliographic Details
Main Authors: Yue WANG, Hui ZHU
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2025-04-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0998
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850144339621052416
author Yue WANG
Hui ZHU
author_facet Yue WANG
Hui ZHU
author_sort Yue WANG
collection DOAJ
description When radiotherapy is administered, many patients exhibit a reduction in lymphocyte numbers due to the inherent radio-sensitivity of lymphocytes. In particular, they experience a decrease in CD8+ T cells, which may weaken their mediated antitumor immune response. While radiotherapy activates the immune system, it can also lead to a certain degree of immunosuppression. Current research suggests that the formation mechanism of radiation-induced lymphopenia (RIL) involves multiple factors, including increased radiation exposure to lymphocytes and the application of lymphocytotoxic drugs. The adverse impact of RIL on patients’ clinical outcomes can be mitigated, to some extent, by actively optimizing radiotherapy dosimetric parameters to maximally protect lymphocytes.
format Article
id doaj-art-04cde19e38974b1b9fd60bdbf122f2bf
institution OA Journals
issn 1000-8578
language zho
publishDate 2025-04-01
publisher Magazine House of Cancer Research on Prevention and Treatment
record_format Article
series Zhongliu Fangzhi Yanjiu
spelling doaj-art-04cde19e38974b1b9fd60bdbf122f2bf2025-08-20T02:28:24ZzhoMagazine House of Cancer Research on Prevention and TreatmentZhongliu Fangzhi Yanjiu1000-85782025-04-0152433734110.3971/j.issn.1000-8578.2025.24.099820240998Research Development of Radiation-Induced LymphopeniaYue WANG0Hui ZHU1Department of Oncology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400037, ChinaDepartment of Oncology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400037, ChinaWhen radiotherapy is administered, many patients exhibit a reduction in lymphocyte numbers due to the inherent radio-sensitivity of lymphocytes. In particular, they experience a decrease in CD8+ T cells, which may weaken their mediated antitumor immune response. While radiotherapy activates the immune system, it can also lead to a certain degree of immunosuppression. Current research suggests that the formation mechanism of radiation-induced lymphopenia (RIL) involves multiple factors, including increased radiation exposure to lymphocytes and the application of lymphocytotoxic drugs. The adverse impact of RIL on patients’ clinical outcomes can be mitigated, to some extent, by actively optimizing radiotherapy dosimetric parameters to maximally protect lymphocytes.http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0998radiation-induced lymphopeniaradiotherapyabsolute lymphocyte counts
spellingShingle Yue WANG
Hui ZHU
Research Development of Radiation-Induced Lymphopenia
Zhongliu Fangzhi Yanjiu
radiation-induced lymphopenia
radiotherapy
absolute lymphocyte counts
title Research Development of Radiation-Induced Lymphopenia
title_full Research Development of Radiation-Induced Lymphopenia
title_fullStr Research Development of Radiation-Induced Lymphopenia
title_full_unstemmed Research Development of Radiation-Induced Lymphopenia
title_short Research Development of Radiation-Induced Lymphopenia
title_sort research development of radiation induced lymphopenia
topic radiation-induced lymphopenia
radiotherapy
absolute lymphocyte counts
url http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.0998
work_keys_str_mv AT yuewang researchdevelopmentofradiationinducedlymphopenia
AT huizhu researchdevelopmentofradiationinducedlymphopenia